Inactive Instrument

News BioNexus Gene Lab Corporation Other OTC

Equities

BGLC

US0906281086

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare	04-18	AQ
BioNexus Gene Lab : Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Form 8-K	04-18	PU
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
BioNexus Gene Lab : Submission of Matters to a Vote of Security Holders - Form 8-K	04-01	PU
BioNexus Gene Lab Corp. Provides Information to Shareholders	02-29	CI
Certain Common Stock of BioNexus Gene Lab Corp. are subject to a Lock-Up Agreement Ending on 18-JAN-2024.	01-17	CI
Soo Kow Lai Provides Information to Shareholders of BioNexus Gene Lab Corp	01-17	CI
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Bionexus Gene Lab Corp. Announces Resignation of Wei Li Leong as Chief Financial Officer	11-03	CI
BioNexus Gene Lab Names Chi Yuen Leong as CEO	23-10-16	MT
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as the Chief Executive Officer	23-10-16	CI
BioNexus Gene Lab Corp. Appoints Mr. Chi Yuen Leong as A Director	23-10-16	CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Chief Executive Officer	23-10-11	CI
BioNexus Gene Lab Corp. Announces Resignation of Sook Keng Yeoh as Board of Directors	23-10-11	CI
BioNexus Gene Lab Corp. Announces Executive Changes	23-09-07	CI
Top Premarket Gainers	23-08-23	MT
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
BioNexus Gene Lab Raises $5.8 Million from Public Share Offering	23-07-24	MT
BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market	23-07-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioNexus Gene Lab Corporation Other OTC

Equities

BGLC

US0906281086

Summary

Filters